Lincoln Pharmaceuticals Ltd Quarterly Results

Gross Sales

168.18

146.55

161.21

147.28

142.49

Excise Duty

0

0

0

0

0

Net Sales

168.18

146.55

161.21

147.28

142.49

Other Operating Income

0

0

0

0

0

Other Income

-6.88

8.97

9.98

10.41

7.02

Total Income

161.3

155.52

171.19

157.69

149.51

Total Expenditure

141.46

122.89

132.83

124.55

124.11

PBIDT

19.84

32.63

38.36

33.14

25.4

Interest

0.37

0.73

0.35

0.44

0.5

PBDT

19.47

31.91

38.01

32.7

24.9

Depreciation

3.23

3.22

3.22

3.22

2.69

Minority Interest Before NP

0

0

0

0

0

Tax

6.65

8.05

5.12

5.51

4.11

Deferred Tax

-1.98

-0.13

3.33

0.29

-0.49

Reported Profit After Tax

11.58

20.77

26.33

23.67

18.6

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

11.58

20.77

26.33

23.67

18.6

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

11.58

20.77

26.33

23.67

18.6

EPS (Unit Curr.)

5.78

10.37

13.15

11.82

9.28

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

20.03

20.03

20.03

20.03

20.03

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

11.79

22.26

23.79

22.5

17.82

PBDTM(%)

11.57

21.77

23.57

22.2

17.47

PATM(%)

6.88

14.17

16.33

16.07

13.05